Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
March 1, 2002
Date of Patent:
August 7, 2007
Assignee:
Lexicon Genetics Incorporated
Inventors:
C. Alexander Turner, Jr., Brian Mathur, Emily B. Cullinan
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
August 28, 2001
Date of Patent:
June 12, 2007
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Carl Johan Friddle, Brenda Gerhardt, Yi Hu
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
April 28, 2004
Date of Patent:
April 3, 2007
Assignee:
Lexicon Genetics Incorporated
Inventors:
D. Wade Walke, Xiaoming Wang, John Scoville, C. Alexander Turner, Jr.
Abstract: This invention concerns novel thiazole compounds. Methods of using these compounds for the treatment, prevention and management of various diseases or disorders, as well as pharmaceutical compositions of these compounds, are also disclosed.
Abstract: The nucleotide and corresponding amino acid sequences are reported for a novel class of mammalian lipoxygenase proteins. The novel lipoxygenase encoding polynucleotides were obtained from human gene trap clones and human cDNA libraries.
Type:
Grant
Filed:
April 23, 2003
Date of Patent:
December 5, 2006
Assignee:
Lexicon Genetics Incorporated
Inventors:
C. Alexander Turner, Jr., Brian Zambrowicz, Michael Nehls, Glenn Friedrich, Arthur T. Sands
Abstract: Noval human polynucleotide and polypeptide sequences are disclosed that can be used in industrial, therapeutic, diagnostic, and pharmacogenomic applications.
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
June 27, 2001
Date of Patent:
July 11, 2006
Assignee:
Lexicon Genetics Incorporated
Inventors:
D. Wade Walke, Carl Johan Friddle, Brian Mathur, C. Alexander Turner, Jr.
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Abstract: The present invention relates to methods and compositions for the treatment of biological disorders regulatable by the controlled expression or inhibition of the described uncoupling proteins (UCPs).
Type:
Grant
Filed:
June 7, 2002
Date of Patent:
January 17, 2006
Assignee:
Lexicon Genetics Incorporated
Inventors:
C. Alexander Turner, Jr., Brian Mathur, Brian Zambrowicz, Arthur T. Sands
Abstract: Disclosed are efficient and scalable processes for preparing 1,2,4- and 1,3,4-oxadiazole carboxylates from readily available starting materials.
Type:
Grant
Filed:
March 19, 2003
Date of Patent:
October 4, 2005
Assignee:
Lexicon Pharmaceuticals, Inc.
Inventors:
Hartmuth C. Kolb, Ramanaiah C. Kanamarlapudi, Paul F. Richardson
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
February 11, 2003
Date of Patent:
August 16, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
C. Alexander Turner, Jr., Glenn Friedrich, Alejandro Abuin, Brian Zambrowicz, Arthur T. Sands, D. Wade Walke, Nathaniel L. Wilganowski
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
March 18, 2004
Date of Patent:
July 19, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
C. Alexander Turner, Jr., Brian Mathur, Carl Johan Friddle
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
July 15, 2003
Date of Patent:
June 21, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
Yi Hu, Boris Nepomnichy, Xiaoming Wang, Gregory Donoho, John Scoville, D. Wade Walke
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
April 11, 2003
Date of Patent:
June 7, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
C. Alexander Turner, Jr., Brian Mathur, Carl Johan Friddle
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
November 25, 2002
Date of Patent:
June 7, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
D. Wade Walke, John Scoville, Gregory Donoho, C. Alexander Turner, Jr., Brian Mathur, Daniel Mathur, Carl Johan Friddle
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
August 28, 2001
Date of Patent:
May 31, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
Carl Johan Friddle, Erin Hilbun, Boris Nepomnichy, Yi Hu
Abstract: Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.
Type:
Grant
Filed:
August 28, 2002
Date of Patent:
May 31, 2005
Assignee:
Lexicon Genetics Incorporated
Inventors:
Gregory Donoho, C. Alexander Turner, Jr., Erin Hilbun, Michael C. Nehls, Glenn Friedrich, Brian Zambrowicz, Arthur T. Sands